Cover Image
Market Research Report
Product code 
950211

Global Male Infertility Market By Treatment, By Test, By Region, Industry Analysis and Forecast, 2020 - 2026

Published: | KBV Research | 173 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Male Infertility Market By Treatment, By Test, By Region, Industry Analysis and Forecast, 2020 - 2026
Published: June 30, 2020
KBV Research
Content info: 173 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Male Infertility Market size is expected to reach $3.2 billion by 2026, rising at a market growth of 7.6% CAGR during the forecast period. Male infertility is the inability of a male to cause pregnancy in a fertile female. A male's fertility relies mainly on the quantity and quality of their sperms. If a man's sperm count is small or if the sperm is of poor quality, it would be difficult, and even impossible, for him to cause pregnancy. The problem of infertility is widespread. Male fertility includes the normal functioning of the hypothalamus, pituitary gland, and testes. Nonetheless, 40 percent-50 percent of cases have no identifiable cause and 30 percent-40 percent of cases are due to problems in the testes.

Continuous R&D efforts are being made to better understand the idiopathic world of infertility. As a result, companies are investing in the development of root cause identification and targeted treatment devices. In addition, the production and commercialization of hormonal therapy are expected to fuel the demand for male infertility during the forecast period. Governments in different countries have taken steps to boost the recovery scenario for infertility-related therapies. In addition, improved safety of patient data due to standardization of legislation is expected to increase consumer demand for infertility treatment.

Advancements in medical testing and rising infertility in males are two of the main factors driving the demand for male infertility. In addition, lifestyle-associated disorders causing infertility, rising obesity, and the expanding aging population are likely to boost the market growth over the forecast period. In the U.S., one-third of cases of infertility are attributed to female factors, one third to male causes, and the other one third is uncertain.

ARTs are used to cure major factors responsible for male infertility. These factors range from sperm autoantibodies, viral orchitis, epididymal dysfunction, accessory gland infections, chemotherapy, to heat, trauma, and other idiopathic factors. High treatment costs and the requirement for several other treatment cycles are some of the key factors contributing to the growth of the segment. Growing spending on health care in developed countries, raising awareness of male infertility, and growing acceptance in middle and low-income countries are the main factors projected to drive the ART segment over the forecast period.

Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.

Scope of the Study

Market Segmentation

By Treatment

  • Assisted Reproductive Technology & Varicocele Surgery and
  • Medication

By Tests

  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Sperm Penetration Assay and
  • Other Tests

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • Sanofi S.A.
  • Bayer AG
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Endo International PLC
  • Aytu BioScience, Inc.
  • Vitrolife AB
  • SCSA Diagnostics, Inc.
  • Andrology Solutions Limited
  • Halotech DNA SL
  • Intas Pharmaceutical Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Male Infertility Market, by Treatment
    • 1.4.2 Global Male Infertility Market, by Tests
    • 1.4.3 Global Male Infertility Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Male Infertility Market by Treatment

  • 3.1 Global Assisted Reproductive Technology and Varicocele Surgery Market by Region
  • 3.2 Global Medication Market by Region

Chapter 4. Global Male Infertility Market by Test

  • 4.1 Global DNA Fragmentation Technique Market by Region
  • 4.2 Global Oxidative Stress Analysis Market by Region
  • 4.3 Global Computer Assisted Semen Analysis Market by Region
  • 4.4 Global Microscopic Examination Market by Region
  • 4.5 Global Sperm Agglutination Market by Region
  • 4.6 Global Sperm Penetration Assay Market by Region
  • 4.7 Global Other Test Market by Region

Chapter 5. Global Male Infertility Market by Region

  • 5.1 North America Male Infertility Market
    • 5.1.1 North America Male Infertility Market by Treatment
      • 5.1.1.1 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country
      • 5.1.1.2 North America Medication Market by Country
    • 5.1.2 North America Male Infertility Market by Test
      • 5.1.2.1 North America DNA Fragmentation Technique Market by Country
      • 5.1.2.2 North America Oxidative Stress Analysis Market by Country
      • 5.1.2.3 North America Computer Assisted Semen Analysis Market by Country
      • 5.1.2.4 North America Microscopic Examination Market by Country
      • 5.1.2.5 North America Sperm Agglutination Market by Country
      • 5.1.2.6 North America Sperm Penetration Assay Market by Country
      • 5.1.2.7 North America Other Test Market by Country
    • 5.1.3 North America Male Infertility Market by Country
      • 5.1.3.1 US Male Infertility Market
        • 5.1.3.1.1 US Male Infertility Market by Treatment
        • 5.1.3.1.2 US Male Infertility Market by Test
      • 5.1.3.2 Canada Male Infertility Market
        • 5.1.3.2.1 Canada Male Infertility Market by Treatment
        • 5.1.3.2.2 Canada Male Infertility Market by Test
      • 5.1.3.3 Mexico Male Infertility Market
        • 5.1.3.3.1 Mexico Male Infertility Market by Treatment
        • 5.1.3.3.2 Mexico Male Infertility Market by Test
      • 5.1.3.4 Rest of North America Male Infertility Market
        • 5.1.3.4.1 Rest of North America Male Infertility Market by Treatment
        • 5.1.3.4.2 Rest of North America Male Infertility Market by Test
  • 5.2 Europe Male Infertility Market
    • 5.2.1 Europe Male Infertility Market by Treatment
      • 5.2.1.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
      • 5.2.1.2 Europe Medication Market by Country
    • 5.2.2 Europe Male Infertility Market by Test
      • 5.2.2.1 Europe DNA Fragmentation Technique Market by Country
      • 5.2.2.2 Europe Oxidative Stress Analysis Market by Country
      • 5.2.2.3 Europe Computer Assisted Semen Analysis Market by Country
      • 5.2.2.4 Europe Microscopic Examination Market by Country
      • 5.2.2.5 Europe Sperm Agglutination Market by Country
      • 5.2.2.6 Europe Sperm Penetration Assay Market by Country
      • 5.2.2.7 Europe Other Test Market by Country
    • 5.2.3 Europe Male Infertility Market by Country
      • 5.2.3.1 Germany Male Infertility Market
        • 5.2.3.1.1 Germany Male Infertility Market by Treatment
        • 5.2.3.1.2 Germany Male Infertility Market by Test
      • 5.2.3.2 UK Male Infertility Market
        • 5.2.3.2.1 UK Male Infertility Market by Treatment
        • 5.2.3.2.2 UK Male Infertility Market by Test
      • 5.2.3.3 France Male Infertility Market
        • 5.2.3.3.1 France Male Infertility Market by Treatment
        • 5.2.3.3.2 France Male Infertility Market by Test
      • 5.2.3.4 Russia Male Infertility Market
        • 5.2.3.4.1 Russia Male Infertility Market by Treatment
        • 5.2.3.4.2 Russia Male Infertility Market by Test
      • 5.2.3.5 Spain Male Infertility Market
        • 5.2.3.5.1 Spain Male Infertility Market by Treatment
        • 5.2.3.5.2 Spain Male Infertility Market by Test
      • 5.2.3.6 Italy Male Infertility Market
        • 5.2.3.6.1 Italy Male Infertility Market by Treatment
        • 5.2.3.6.2 Italy Male Infertility Market by Test
      • 5.2.3.7 Rest of Europe Male Infertility Market
        • 5.2.3.7.1 Rest of Europe Male Infertility Market by Treatment
        • 5.2.3.7.2 Rest of Europe Male Infertility Market by Test
  • 5.3 Asia Pacific Male Infertility Market
    • 5.3.1 Asia Pacific Male Infertility Market by Treatment
      • 5.3.1.1 Asia Pacific Assisted Reproductive Technology and Varicocele Surgery Market by Country
      • 5.3.1.2 Asia Pacific Medication Market by Country
    • 5.3.2 Asia Pacific Male Infertility Market by Test
      • 5.3.2.1 Asia Pacific DNA Fragmentation Technique Market by Country
      • 5.3.2.2 Asia Pacific Oxidative Stress Analysis Market by Country
      • 5.3.2.3 Asia Pacific Computer Assisted Semen Analysis Market by Country
      • 5.3.2.4 Asia Pacific Microscopic Examination Market by Country
      • 5.3.2.5 Asia Pacific Sperm Agglutination Market by Country
      • 5.3.2.6 Asia Pacific Sperm Penetration Assay Market by Country
      • 5.3.2.7 Asia Pacific Other Test Market by Country
    • 5.3.3 Asia Pacific Male Infertility Market by Country
      • 5.3.3.1 India Male Infertility Market
        • 5.3.3.1.1 India Male Infertility Market by Treatment
        • 5.3.3.1.2 India Male Infertility Market by Test
      • 5.3.3.2 China Male Infertility Market
        • 5.3.3.2.1 China Male Infertility Market by Treatment
        • 5.3.3.2.2 China Male Infertility Market by Test
      • 5.3.3.3 Japan Male Infertility Market
        • 5.3.3.3.1 Japan Male Infertility Market by Treatment
        • 5.3.3.3.2 Japan Male Infertility Market by Test
      • 5.3.3.4 South Korea Male Infertility Market
        • 5.3.3.4.1 South Korea Male Infertility Market by Treatment
        • 5.3.3.4.2 South Korea Male Infertility Market by Test
      • 5.3.3.5 Singapore Male Infertility Market
        • 5.3.3.5.1 Singapore Male Infertility Market by Treatment
        • 5.3.3.5.2 Singapore Male Infertility Market by Test
      • 5.3.3.6 Malaysia Male Infertility Market
        • 5.3.3.6.1 Malaysia Male Infertility Market by Treatment
        • 5.3.3.6.2 Malaysia Male Infertility Market by Test
      • 5.3.3.7 Rest of Asia Pacific Male Infertility Market
        • 5.3.3.7.1 Rest of Asia Pacific Male Infertility Market by Treatment
        • 5.3.3.7.2 Rest of Asia Pacific Male Infertility Market by Test
  • 5.4 LAMEA Male Infertility Market
    • 5.4.1 LAMEA Male Infertility Market by Treatment
      • 5.4.1.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
      • 5.4.1.2 LAMEA Medication Market by Country
    • 5.4.2 LAMEA Male Infertility Market by Test
      • 5.4.2.1 LAMEA DNA Fragmentation Technique Market by Country
      • 5.4.2.2 LAMEA Oxidative Stress Analysis Market by Country
      • 5.4.2.3 LAMEA Computer Assisted Semen Analysis Market by Country
      • 5.4.2.4 LAMEA Microscopic Examination Market by Country
      • 5.4.2.5 LAMEA Sperm Agglutination Market by Country
      • 5.4.2.6 LAMEA Sperm Penetration Assay Market by Country
      • 5.4.2.7 LAMEA Other Test Market by Country
    • 5.4.3 LAMEA Male Infertility Market by Country
      • 5.4.3.1 Brazil Male Infertility Market
        • 5.4.3.1.1 Brazil Male Infertility Market by Treatment
        • 5.4.3.1.2 Brazil Male Infertility Market by Test
      • 5.4.3.2 Argentina Male Infertility Market
        • 5.4.3.2.1 Argentina Male Infertility Market by Treatment
        • 5.4.3.2.2 Argentina Male Infertility Market by Test
      • 5.4.3.3 UAE Male Infertility Market
        • 5.4.3.3.1 UAE Male Infertility Market by Treatment
        • 5.4.3.3.2 UAE Male Infertility Market by Test
      • 5.4.3.4 Saudi Arabia Male Infertility Market
        • 5.4.3.4.1 Saudi Arabia Male Infertility Market by Treatment
        • 5.4.3.4.2 Saudi Arabia Male Infertility Market by Test
      • 5.4.3.5 South Africa Male Infertility Market
        • 5.4.3.5.1 South Africa Male Infertility Market by Treatment
        • 5.4.3.5.2 South Africa Male Infertility Market by Test
      • 5.4.3.6 Nigeria Male Infertility Market
        • 5.4.3.6.1 Nigeria Male Infertility Market by Treatment
        • 5.4.3.6.2 Nigeria Male Infertility Market by Test
      • 5.4.3.7 Rest of LAMEA Male Infertility Market
        • 5.4.3.7.1 Rest of LAMEA Male Infertility Market by Treatment
        • 5.4.3.7.2 Rest of LAMEA Male Infertility Market by Test

Chapter 6. Company Profiles

  • 6.1 Sanofi S.A.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 Bayer AG
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cadila Healthcare Ltd. (Zydus Cadila)
    • 6.3.1 Company Overview
    • 6.3.1 Financial Analysis
    • 6.3.2 Regional Analysis
    • 6.3.3 Research & Development Expense
  • 6.4 Endo International PLC
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 Aytu BioScience, Inc.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Regional Analysis
    • 6.5.4 Research & Development Expenses
    • 6.5.5 Recent strategies and developments:
      • 6.5.5.1 Acquisition and Mergers:
      • 6.5.5.2 Partnerships, Collaborations, and Agreements:
  • 6.6 Vitrolife AB
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Regional Analysis
    • 6.6.4 Research & Development Expenses
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Partnerships, Collaborations, and Agreements:
  • 6.7 SCSA Diagnostics, Inc.
    • 6.7.1 Company Overview
  • 6.8 Andrology Solutions Limited
    • 6.8.1 Company Overview
  • 6.9 Halotech DNA SL
    • 6.9.1 Company Overview
  • 6.1 Intas Pharmaceutical Ltd.
    • 6.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 GLOBAL MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 GLOBAL MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 GLOBAL MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 4 GLOBAL MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 5 GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 6 GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 7 GLOBAL MEDICATION MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 8 GLOBAL MEDICATION MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 9 GLOBAL MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 10 GLOBAL MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 11 GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 12 GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 13 GLOBAL OXIDATIVE STRESS ANALYSIS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 14 GLOBAL OXIDATIVE STRESS ANALYSIS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 15 GLOBAL COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 16 GLOBAL COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 17 GLOBAL MICROSCOPIC EXAMINATION MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 18 GLOBAL MICROSCOPIC EXAMINATION MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 19 GLOBAL SPERM AGGLUTINATION MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 20 GLOBAL SPERM AGGLUTINATION MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 21 GLOBAL SPERM PENETRATION ASSAY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 22 GLOBAL SPERM PENETRATION ASSAY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 23 GLOBAL OTHER TEST MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 24 GLOBAL OTHER TEST MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 25 GLOBAL MALE INFERTILITY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 26 GLOBAL MALE INFERTILITY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 27 NORTH AMERICA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 28 NORTH AMERICA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 29 NORTH AMERICA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 30 NORTH AMERICA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 31 NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 32 NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 33 NORTH AMERICA MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 34 NORTH AMERICA MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 35 NORTH AMERICA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 36 NORTH AMERICA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 37 NORTH AMERICA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 38 NORTH AMERICA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 39 NORTH AMERICA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 40 NORTH AMERICA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 41 NORTH AMERICA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 42 NORTH AMERICA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 43 NORTH AMERICA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 44 NORTH AMERICA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 45 NORTH AMERICA SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 46 NORTH AMERICA SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 47 NORTH AMERICA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 48 NORTH AMERICA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 49 NORTH AMERICA OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 50 NORTH AMERICA OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 51 NORTH AMERICA MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 52 NORTH AMERICA MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 53 US MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 54 US MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 55 US MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 56 US MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 57 US MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 58 US MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 59 CANADA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 60 CANADA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 61 CANADA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 62 CANADA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 63 CANADA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 64 CANADA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 65 MEXICO MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 66 MEXICO MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 67 MEXICO MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 68 MEXICO MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 69 MEXICO MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 70 MEXICO MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 71 REST OF NORTH AMERICA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 72 REST OF NORTH AMERICA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 73 REST OF NORTH AMERICA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 74 REST OF NORTH AMERICA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 75 REST OF NORTH AMERICA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 76 REST OF NORTH AMERICA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 77 EUROPE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 78 EUROPE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 79 EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 80 EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 81 EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 82 EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 83 EUROPE MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 84 EUROPE MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 85 EUROPE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 86 EUROPE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 87 EUROPE DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 88 EUROPE DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 89 EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 90 EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 91 EUROPE COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 92 EUROPE COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 93 EUROPE MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 94 EUROPE MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 95 EUROPE SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 96 EUROPE SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 97 EUROPE SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 98 EUROPE SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 99 EUROPE OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 100 EUROPE OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 101 EUROPE MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 102 EUROPE MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 103 GERMANY MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 104 GERMANY MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 105 GERMANY MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 106 GERMANY MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 107 GERMANY MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 108 GERMANY MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 109 UK MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 110 UK MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 111 UK MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 112 UK MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 113 UK MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 114 UK MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 115 FRANCE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 116 FRANCE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 117 FRANCE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 118 FRANCE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 119 FRANCE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 120 FRANCE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 121 RUSSIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 122 RUSSIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 123 RUSSIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 124 RUSSIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 125 RUSSIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 126 RUSSIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 127 SPAIN MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 128 SPAIN MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 129 SPAIN MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 130 SPAIN MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 131 SPAIN MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 132 SPAIN MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 133 ITALY MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 134 ITALY MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 135 ITALY MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 136 ITALY MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 137 ITALY MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 138 ITALY MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 139 REST OF EUROPE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 140 REST OF EUROPE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 141 REST OF EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 142 REST OF EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 143 REST OF EUROPE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 144 REST OF EUROPE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 145 ASIA PACIFIC MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 146 ASIA PACIFIC MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 147 ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 148 ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 149 ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 150 ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 151 ASIA PACIFIC MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 152 ASIA PACIFIC MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 153 ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 154 ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 155 ASIA PACIFIC DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 156 ASIA PACIFIC DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 157 ASIA PACIFIC OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 158 ASIA PACIFIC OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 159 ASIA PACIFIC COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 160 ASIA PACIFIC COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 161 ASIA PACIFIC MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 162 ASIA PACIFIC MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 163 ASIA PACIFIC SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 164 ASIA PACIFIC SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 165 ASIA PACIFIC SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 166 ASIA PACIFIC SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 167 ASIA PACIFIC OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 168 ASIA PACIFIC OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 169 ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 170 ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 171 INDIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 172 INDIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 173 INDIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 174 INDIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 175 INDIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 176 INDIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 177 CHINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 178 CHINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 179 CHINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 180 CHINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 181 CHINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 182 CHINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 183 JAPAN MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 184 JAPAN MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 185 JAPAN MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 186 JAPAN MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 187 JAPAN MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 188 JAPAN MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 189 SOUTH KOREA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 190 SOUTH KOREA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 191 SOUTH KOREA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 192 SOUTH KOREA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 193 SOUTH KOREA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 194 SOUTH KOREA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 195 SINGAPORE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 196 SINGAPORE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 197 SINGAPORE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 198 SINGAPORE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 199 SINGAPORE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 200 SINGAPORE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 201 MALAYSIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 202 MALAYSIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 203 MALAYSIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 204 MALAYSIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 205 MALAYSIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 206 MALAYSIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 207 REST OF ASIA PACIFIC MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 208 REST OF ASIA PACIFIC MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 209 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 210 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 211 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 212 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 213 LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 214 LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 215 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 216 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 217 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 218 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 219 LAMEA MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 220 LAMEA MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 221 LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 222 LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 223 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 224 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 225 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 226 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 227 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 228 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 229 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 230 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 231 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 232 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 233 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 234 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 235 LAMEA OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 236 LAMEA OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 237 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 238 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 239 BRAZIL MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 240 BRAZIL MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 241 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 242 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 243 BRAZIL MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 244 BRAZIL MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 245 ARGENTINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 246 ARGENTINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 247 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 248 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 249 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 250 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 251 UAE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 252 UAE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 253 UAE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 254 UAE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 255 UAE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 256 UAE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 257 SAUDI ARABIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 258 SAUDI ARABIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 259 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 260 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 261 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 262 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 263 SOUTH AFRICA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 264 SOUTH AFRICA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 265 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 266 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 267 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 268 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 269 NIGERIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 270 NIGERIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 271 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 272 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 273 NIGERIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 274 NIGERIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 275 REST OF LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 276 REST OF LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 277 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 278 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 279 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 280 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 281 KEY INFORMATION - SANOFI S.A.
  • TABLE 282 KEY INFORMATION - BAYER AG
  • TABLE 283 KEY INFORMATION - CADILA HEALTHCARE LTD.
  • TABLE 284 KEY INFORMATION - ENDO INTERNATIONAL PLC
  • TABLE 285 KEY INFORMATION - AYTU BIOSCIENCE, INC.
  • TABLE 286 KEY INFORMATION - VITROLIFE AB
  • TABLE 287 KEY INFORMATION - SCSA DIAGNOSTICS, INC.
  • TABLE 288 KEY INFORMATION - ANDROLOGY SOLUTIONS LIMITED
  • TABLE 289 KEY INFORMATION - HALOTECH DNA SL
  • TABLE 290 KEY INFORMATION - INTAS PHARMACEUTICAL LTD.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH